Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Clinical trial NCT06572228 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06572228
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-26
- Primary completion
- 2027-04-24
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.